These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1593308)

  • 1. Insulin resistance and essential hypertension: pathophysiologic and therapeutic implications.
    Santucci A; Ferri C
    J Hypertens Suppl; 1992 Apr; 10(2):S9-15. PubMed ID: 1593308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperinsulinemia, insulin resistance, and hypertension.
    Bönner G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin resistance and arterial hypertension].
    Weidmann P; Müller-Wieland D; de Courten M; Krone W
    Herz; 1995 Feb; 20(1):16-32. PubMed ID: 7713473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin sensitivity in newly detected hypertensive patients: influence of captopril and other antihypertensive agents on insulin sensitivity and related biological parameters.
    Lithell HO; Pollare T; Berne C
    J Cardiovasc Pharmacol; 1990; 15 Suppl 5():S46-52. PubMed ID: 1694931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension and insulin resistance.
    Prichard BN; Smith CC; Sen S; Betteridge DJ
    J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S77-84. PubMed ID: 1284147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
    Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxonidine improves insulin sensitivity in insulin-resistant hypertensives.
    Haenni A; Lithell H
    J Hypertens Suppl; 1999 Aug; 17(3):S29-35. PubMed ID: 10489096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate metabolism in hypertension: influence of treatment.
    Gambardella S; Frontoni S; Pellegrinotti M; Testa G; Spallone V; Menzinger G
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S87-97. PubMed ID: 7508068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is insulin resistance a predictor of the blood pressure response to anti-hypertensive treatment?
    Lind L; Berne C; Andersson PE; Hänni A; Lithell H
    J Hum Hypertens; 1995 Sep; 9(9):759-63. PubMed ID: 8551491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):359-67. PubMed ID: 15025845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and hypertension.
    Hsueh WA; Buchanan TA
    Endocrinol Metab Clin North Am; 1994 Jun; 23(2):405-27. PubMed ID: 8070430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperinsulinism/insulin resistance: cause, effect or marker of essential arterial hypertension?].
    Greco D; Sinagra D
    G Ital Cardiol; 1995 Feb; 25(2):207-16. PubMed ID: 7642026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of insulin resistance in essential hypertension.
    Lind L; Berne C; Lithell H
    J Hypertens; 1995 Dec; 13(12 Pt 1):1457-62. PubMed ID: 8866908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coronary artery disease paradox: the role of hyperinsulinemia and insulin resistance and implications for therapy.
    Black HR
    J Cardiovasc Pharmacol; 1990; 15 Suppl 5():S26-38. PubMed ID: 1694928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and upper-normal glucose levels in hypertension: a review.
    Cubeddu LX; Hoffmann IS
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S52-5. PubMed ID: 11986895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.